您的位置：
首页
>
农业专利
>
详情页
接受體外光量子療法之細胞與ＴＮＦ拮抗劑之組合產品
专利权人:
INC.;THERAKOS
发明人:
PERITT, DAVID,彼大卫,彼大衛,CAMPBELL, KIM,康金,GILES-KOMAR, JILL,基吉尔,基吉爾,HARRIMAN, GREGORY,哈乔治,哈喬治
申请号：
TW093139924
公开号：
TWI419721B
申请日:
2004.12.22
申请国别(地区):
TW
年份:
2013
代理人:
摘要：
Methods of treating an autoimmune disease, an atopic disease, transplantation rejection or GVHD or ameliorating one or more symptoms thereof involves the use of a combination therapy. The therapy involves administering to a subject an extracorporeal photopheresis and a TNF α antagonist.用以治療一自體免疫疾病、異位性疾病、移植排斥或GVHD或減輕其一或多種症狀之方法，其關於使用一組合療法。該療法涉及將一體外光量子療法與一TNF-α拮抗劑投予一個體。
来源网站：
中国工程科技知识中心
来源网址：
http://www.ckcest.cn/home/
相关专利
Prevention and treatment of graft versus host disease by defensin
Binding Protein that specifically binds to TNF alpha； Nucleic Acid Coding； vector； host Cell； production method； Pharmaceutical composition that comprises； and their use for treating a disease or a disorder associated with TNF alpha.
simple variable domain, multispecific ligand, tnfr1, and tnf-alpha receptor antagonists, use of tnfr agonist, anti-tnfr1 antagonist, polypeptide or multispecific ligand, method for treating and / or preventing a condition or disease, nucleic acid, vector and host
Link Protein that binds to tumor necrosis factor alpha (TNF alpha)； Nucleic Acid Coding； vector； host Cell； production method； Pharmaceutical composition that comprises； its use to treat a disorder associated with TNF alpha； and a method for determining the presence of TNF -. In a sample.
БІЛОК, ЯКИЙ ЗВ'ЯЗУЄ TNF-α
